Nov 3, 2026 9:00am EST Capricor Therapeutics to Report Third Quarter 2026 Financial Results and Provide Recent Corporate Update on November 10
Oct 5, 2026 9:00am EDT Capricor Therapeutics Presents Positive HOPE-3 Open-Label Extension Data on Upper Limb Function in Duchenne Muscular Dystrophy at 2026 World Muscle Society Congress
Nov 10, 2026 4:30 pm EST Capricor Therapeutics Third Quarter 2026 Financial Results and Corporate Update Conference Call